Latest the Journal of Clinical Investigation Stories
A recent discovery by scientists at A*STAR’s Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalized treatment strategy that could use a patient’s own blood to treat the infection.
Cedars-Sinai researchers have found that a common vitamin may have the potential to provide a powerful weapon to fight certain "superbugs," antibiotic-resistant staph infections that health experts see as a threat to public health.
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
If the brain goes hungry, Twinkies look a lot better.
Widespread vascular tumors, massive hemorrhage and death reported in mice.
Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection.
One of the many advantages of maintaining a normal body weight is having healthy fat, which in turn supports a healthy heart.
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders.
Substance in iron metabolism displays life-saving potential for inflammatory diseases.
UT Southwestern Medical Center researchers have found that a naturally occurring protein â€” transforming growth factor beta1 (TGF-ÃŸ1) â€” which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.
- A transitional zone between two communities containing the characteristic species of each.